Key result
Nicardipine was associated with improved infusion rate stability requiring fewer dose changes per hour compared to sodium nitroprusside, with no significant difference in costs.
Why the study?
Does nicardipine improve infusion rate stability and reduce postoperative costs compared to sodium nitroprusside in adults with postcardiac surgery hypertension?
Cohort (n=112)
No
Does nicardipine improve infusion rate stability and reduce postoperative costs compared to sodium nitroprusside in adults with postcardiac surgery hypertension?
Nicardipine provides similar blood pressure control to sodium nitroprusside with improved infusion rate stability and no significant difference in postoperative costs in patients after cardiac surgery.
Answers are grounded in this paper and cite their sources.
May favor nicardipine for infusion stability after cardiac surgery; leaves open randomized trials on outcomes.
Background Postoperative hypertension after cardiac surgery is associated with substantial morbidity. Both sodium nitroprusside (SNP) and nicardipine (NIC) are effective in its management. Outcomes data for NIC and SNP in persons undergoing cardiac surgery are limited, and there are no data characterizing the influence of drug choice on postoperative costs. Objective Our aim was to compare the effectiveness of NIC versus SNP in the management of hypertension after cardiac surgery and evaluate the influence of drug choice on postoperative costs. Methods We conducted a retrospective, cohort study using our hospital's financial and electronic medical records. Adults admitted to a cardiothoracic surgical intensive care unit after coronary artery bypass grafting (CABG) and/or valve surgery who developed hypertension requiring ≥30 minutes of NIC or SNP were included. We evaluated drug effectiveness by assessing infusion rate stability, blood pressure and heart rate, and concomitant antihypertensive agent use. Activity-based postoperative costs were compared between study groups. Results One hundred twelve subjects were included (NIC = 72, SNP = 40). Hypertension-related demographics were balanced between the groups. NIC was associated with improved infusion rate stability that required fewer dose changes per hour (1.2 ± 1.6) versus SNP (1.7 ± 1.8) ( P = .004). Heart rates and blood pressures did not differ significantly. The number of antihypertensive medications used before and during the NIC or SNP infusions was the same. However, persons who were prescribed SNP required significantly more medications to manage blood pressure after infusions were discontinued ( P = .001). NIC use did not significantly increase postoperative cost. NIC use may be associated with cost increases in isolated CABG but with cost savings in isolated valve or combined CABG/valve surgeries; however, these differences were not statistically significant. Conclusions Blood pressure was equally controlled using NIC or SNP. NIC was associated with improved infusion rate stability. Despite a higher acquisition cost, NIC did not significantly influence postoperative costs. Larger, prospective cost-effective analyses in surgical subgroups are needed.
No takes yet. Share an insight, caveat, or question.
Barnes et al. (2012) conducted a cohort in Postoperative hypertension after cardiac surgery (n=112). Nicardipine vs. Sodium nitroprusside was evaluated on Infusion rate stability (dose changes per hour) (p=0.004). Nicardipine was associated with improved infusion rate stability requiring fewer dose changes per hour compared to sodium nitroprusside, with no significant difference in costs.
Synapse has enriched 10 related papers. Consider them for comparative context: